Human	B-protein
neutrophil	I-protein
elastase	I-protein
proteolytically	O
activates	O
the	O
platelet	B-protein
integrin	I-protein
alphaIIbbeta3	B-protein
through	O
cleavage	O
of	O
the	O
carboxyl	B-protein
terminus	I-protein
of	O
the	O
alphaIIb	B-protein
subunit	I-protein
heavy	I-protein
chain	I-protein
.	O

Involvement	O
in	O
the	O
potentiation	O
of	O
platelet	O
aggregation	O
.	O

Neutrophil	B-protein
elastase	I-protein
(	O
NE	B-protein
)	O
and	O
cathepsin	B-protein
G	I-protein
are	O
two	O
serine	B-protein
proteinases	I-protein
released	O
concomitantly	O
by	O
stimulated	O
polymorphonuclear	B-cell_type
neutrophils	I-cell_type
.	O

We	O
previously	O
demonstrated	O
that	O
while	O
NE	B-protein
by	O
itself	O
does	O
not	O
activate	O
human	B-cell_type
platelets	I-cell_type
,	O
it	O
strongly	O
enhances	O
the	O
weak	O
aggregation	O
induced	O
by	O
a	O
threshold	O
concentration	O
of	O
cathepsin	B-protein
G	I-protein
(	O
threshold	O
of	O
cathepsin	B-protein
G	I-protein
)	O
(	O
Renesto	O
,	O
P.	O
,	O
and	O
Chignard	O
,	O
M.	O
(	O
1993	O
)	O
Blood	O
82	O
,	O
139-144	O
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
delineate	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
this	O
potentiation	O
process	O
.	O

Two	O
main	O
pieces	O
of	O
data	O
prompted	O
us	O
to	O
focus	O
on	O
the	O
activation	O
of	O
the	O
platelet	B-protein
fibrinogen	I-protein
receptor	I-protein
,	O
the	O
alphaIIbbeta3	B-protein
integrin	I-protein
.	O

First	O
,	O
previous	O
studies	O
have	O
shown	O
this	O
integrin	B-protein
to	O
be	O
particularly	O
prone	O
to	O
proteolytic	O
regulation	O
of	O
its	O
function	O
.	O

Second	O
,	O
we	O
found	O
that	O
the	O
potentiating	O
activity	O
of	O
NE	B-protein
on	O
the	O
threshold	O
of	O
cathepsin	B-protein
G	I-protein
-induced	O
platelet	O
aggregation	O
was	O
strictly	O
dependent	O
on	O
the	O
presence	O
of	O
exogenous	B-protein
fibrinogen	I-protein
.	O

Using	O
flow	O
cytometry	O
analysis	O
,	O
NE	B-protein
was	O
shown	O
to	O
trigger	O
a	O
time-dependent	O
binding	O
of	O
PAC-1	B-protein
and	O
AP-5	B-protein
,	O
two	O
monoclonal	B-protein
antibodies	I-protein
specific	O
for	O
the	O
activated	O
and	O
ligand-occupied	O
conformers	O
of	O
alphaIIbbeta3	B-protein
.	O

Furthermore	O
,	O
the	O
potentiated	O
aggregation	O
was	O
shown	O
to	O
result	O
from	O
an	O
increased	O
capacity	O
of	O
platelets	O
to	O
bind	O
fibrinogen	O
.	O

Indeed	O
,	O
the	O
combination	O
of	O
NE	B-protein
and	O
threshold	O
of	O
cathepsin	B-protein
G	I-protein
increased	O
the	O
binding	O
of	O
PAC-1	B-protein
approximately	O
5.5-fold	O
over	O
basal	O
values	O
measured	O
on	O
nontreated	B-cell_type
platelets	I-cell_type
,	O
whereas	O
this	O
binding	O
raised	O
only	O
by	O
approximately	O
3-fold	O
in	O
threshold	O
of	O
cathepsin	B-cell_type
G-stimulated	I-cell_type
platelets	I-cell_type
(	O
p	O
<	O
0.05	O
)	O
.	O

By	O
contrast	O
,	O
phosphatidic	O
acid	O
accumulation	O
,	O
pleckstrin	O
phosphorylation	O
,	O
and	O
calcium	O
mobilization	O
produced	O
by	O
the	O
combination	O
of	O
NE	B-protein
and	O
threshold	O
of	O
cathepsin	B-protein
G	I-protein
were	O
not	O
significantly	O
different	O
from	O
those	O
measured	O
with	O
threshold	O
of	O
cathepsin	B-protein
G	I-protein
alone	O
(	O
p	O
>	O
0.05	O
)	O
,	O
indicating	O
that	O
the	O
phospholipase	B-protein
C	I-protein
/protein	B-protein
kinase	I-protein
C	I-protein
pathway	O
is	O
not	O
involved	O
in	O
the	O
potentiation	O
of	O
aggregation	O
.	O

The	O
foregoing	O
data	O
,	O
as	O
well	O
as	O
the	O
requirement	O
of	O
catalytically	O
active	O
NE	B-protein
to	O
trigger	O
alphaIIbbeta3	B-protein
activation	O
and	O
potentiate	O
threshold	O
of	O
cathepsin	B-protein
G	I-protein
-initiated	O
platelet	O
aggregation	O
,	O
led	O
us	O
to	O
examine	O
whether	O
the	O
structure	O
of	O
this	O
integrin	B-protein
was	O
affected	O
by	O
NE	B-protein
.	O

Immunoblot	O
and	O
flow	O
cytometry	O
analysis	O
revealed	O
a	O
limited	O
proteolysis	O
of	O
the	O
carboxyl	B-protein
terminus	I-protein
of	O
the	O
alphaIIb	B-protein
subunit	I-protein
heavy	I-protein
chain	I-protein
(	O
alphaIIbH	B-protein
)	O
,	O
as	O
judged	O
by	O
the	O
disappearance	O
of	O
the	O
epitope	O
for	O
the	O
monoclonal	B-protein
antibody	I-protein
PMI-1	I-protein
.	O

Mass	O
spectrometry	O
studies	O
performed	O
on	O
a	O
synthetic	O
peptide	O
mapping	O
over	O
the	O
cleavage	B-protein
domain	I-protein
of	O
alphaIIbH	B-protein
predicted	O
the	O
site	O
of	O
proteolysis	O
as	O
located	O
between	O
Val837	O
and	O
Asp838	O
.	O

Treatment	O
by	O
NE	B-protein
of	O
ATP-depleted	B-cell_type
platelets	I-cell_type
or	O
Chinese	B-cell_line
hamster	I-cell_line
ovary	I-cell_line
cells	I-cell_line
expressing	O
human	B-protein
recombinant	I-protein
alphaIIbbeta3	I-protein
clearly	O
established	O
that	O
activation	O
of	O
the	O
integrin	B-protein
was	O
independent	O
of	O
signal	O
transduction	O
events	O
and	O
was	O
concomitant	O
with	O
the	O
proteolysis	O
of	O
alphaIIbH	B-protein
.	O

